By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living ...

Researchers believe a usually harmless virus could trigger Parkinson’s disease. Five out of 10 post-mortem brains of patients ...

Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...